Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.

Track visits and conversions and automatically synchronise them with your digital Advertising channels. Optimize your marketing spend without painful implementation tracks. Perfect clarity, in your sales channel. Metrion seamlessly tracks data directly on your own server and integrates it with your preferred sales channels.

Discover the history of Metrion Biosciences, from its founding in 2015 to becoming a global leader in ion channel drug discovery and CRO services.

Metrion Biosciences is a specialist preclinical drug discovery CRO - your trusted partner for ion channel screening, cardiac safety screening and neuroscience assays.

2023年12月20日 · 英国剑桥--（商业新闻短讯）--Metrion Biosciences Limited（Metrion）是专业的离子通道CRO和药物发现公司，今天宣布，它已获得350万英镑的新股权融资，其中包括来自主要投资者Maven Capital Partners（Maven）的250万英镑和来自现有投资者Gresham House Ventures（Gresham House）的100万 ...

2023年12月20日 · Metrion Biosciences Limited是一家英国合同研究机构，专门从事高质量的离子通道筛选和药物开发，我们的目标是为客户提供一系列的体外筛选服务，包括心脏安全(herg，cipa panel of human cardiac ion channels)和神经病理学检测。

2021年2月1日，药物研发公司Metrion Biosciences Limited与Sosei Group Corporation宣布双方将通过新的战略合作，首次将Sosei Heptares领先的基于结构的药物设计（SBDD）专业技术和平台应用于离子通道。

Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services. Visit our LinkedIn Visit our Twitter

Operator of a contract research organization intended to focus on delivering a range of preclinical drug discovery screening services.

Choose Metrion as your CRO for ion channel screening, cardiac safety, and neuroscience research. Expertise, advanced technology, and proven reliability.